Clinical Trials for Grit Biotechnology

Explore 25 clinical trials worldwide

Showing 1-25 of 25 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Grit Biotechnology

Clinical Trials (25)

NCT07205315
A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies
EARLY_PHASE1Recruiting
28 participants
Started: Sep 30, 2025 · Completed: Aug 31, 2028
1 condition2 sponsors1 location
NCT07132112
GT719 Injection for Moderate to Severe Refractory Autoimmune Disease
EARLY_PHASE1Not yet recruiting
30 participants
Started: Aug 31, 2025 · Completed: Aug 31, 2028
1 condition2 sponsors1 location
NCT07122076
GT719 Injection for Moderate to Severe Refractory Autoimmune Diseases
EARLY_PHASE1Recruiting
10 participants
Started: Aug 22, 2025 · Completed: Aug 21, 2028
1 condition1 sponsor1 location
NCT06948981
GT719 Injection for the Treatment of Recurrent/Refractory CD19 Positive Adult B-cell Malignancies
PHASE1/PHASE2Recruiting
46 participants
Started: Apr 18, 2025 · Completed: Apr 17, 2028
1 condition2 sponsors1 location
NCT07021209
GT719 Injection for Recurrent/Refractory Antibody-mediated Neurological Immune Diseases
PHASE1Recruiting
30 participants
Started: Jan 14, 2025 · Completed: Jan 13, 2028
1 condition2 sponsors1 location
NCT06819293
IB-T101 Injection for Treatment of Patients with Advanced Clear Cell Renal Cell Carcinoma
PHASE1Recruiting
12 participants
Started: Dec 6, 2024 · Completed: Dec 7, 2027
2 conditions1 sponsor1 location
NCT07131254
GT719 Injection for CD19 Positive Recurrent/Refractory Adult B-cell Malignancies
PHASE1/PHASE2Recruiting
34 participants
Started: Sep 25, 2024 · Completed: Sep 24, 2027
1 condition2 sponsors1 location
NCT06519669
Autologous Tumor-Infiltrating Lymphocyte Injection(GT201) for Treatment of Patients with Advanced Lung Cancer
NARecruiting
40 participants
Started: Jul 18, 2024 · Completed: Jul 18, 2027
2 conditions1 sponsor2 locations
NCT06491225
Autologous Tumor-Infiltrating Lymphocyte (GTE-001 Injection ) for Treatment of Patients with Advanced Lung Adenocarcinoma
PHASE1Recruiting
12 participants
Started: Jul 18, 2024 · Completed: Jul 18, 2027
1 condition1 sponsor1 location
NCT06453057
Autologous Tumor-Infiltrating Lymphocyte (GT307) for Treatment of Patients with Solid Tumours
NARecruiting
18 participants
Started: Jul 4, 2024 · Completed: Jun 6, 2027
1 condition1 sponsor1 location
NCT06819280
Autologous Tumor-Infiltrating Lymphocyte (GT307) for Treatment of Patients with Advanced Colorectal Cancer
NARecruiting
18 participants
Started: Jun 28, 2024 · Completed: May 27, 2027
1 condition1 sponsor1 location
NCT06190275
Clinical Study of GT201 in Combination with PD-1 Inhibitor for Advanced Head and Neck Tumors
NARecruiting
12 participants
Started: May 12, 2024 · Completed: Apr 30, 2027
1 condition1 sponsor1 location
NCT06397963
Autologous Tumor-Infiltrating Lymphocyte (GT307 Injection ) for Treatment of Patients with Solid Tumours
NARecruiting
18 participants
Started: Apr 18, 2024 · Completed: Apr 18, 2027
1 condition1 sponsor2 locations
NCT06241781
Autologous Tumor Infiltrating Lymphocytes (GT101 Injection) in Patients with Recurrent or Metastatic Cervical Cancer
PHASE2Recruiting
83 participants
Started: Apr 2, 2024 · Completed: Jan 31, 2027
1 condition1 sponsor24 locations
NCT06235242
GT201 Injection in Combination with Teraplizumab Injection for Treatment of Patients with Non-small Cell Lung Cancer
NARecruiting
20 participants
Started: Feb 2, 2024 · Completed: Jan 31, 2027
2 conditions1 sponsor3 locations
NCT06144671
GT201 Injection For The Treatment Of Advanced Solid Tumors
PHASE1/PHASE2Recruiting
18 participants
Started: Sep 13, 2023 · Completed: Sep 13, 2026
1 condition1 sponsor4 locations
NCT06191900
Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors (advanced Cervical Cancer)
NARecruiting
26 participants
Started: Jun 5, 2023 · Completed: Jun 5, 2026
2 conditions1 sponsor1 location
NCT06145802
Clinical Study of Autologous Tumor Infiltrating Lymphocyte Injection (GT316) in the Treatment of Advanced Solid Tumors (gynecological Tumors)
NARecruiting
36 participants
Started: Mar 9, 2023 · Completed: Mar 9, 2026
2 conditions1 sponsor1 location
NCT06094426
Autologous Tumor Infiltrating Lymphocyte Injection for the Treatment of Advanced Solid Tumors
EARLY_PHASE1Recruiting
36 participants
Started: Feb 26, 2023 · Completed: Feb 26, 2026
3 conditions1 sponsor1 location
NCT06834542
Clinical Study of GT201 in the Treatment of Advanced Gynecological Tumors
EARLY_PHASE1Recruiting
26 participants
Started: Nov 1, 2022 · Completed: Oct 31, 2026
1 condition1 sponsor1 location
NCT05729399
Clinical Study of Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for Advanced Solid Tumors
PHASE1/PHASE2Recruiting
42 participants
Started: Sep 14, 2022 · Completed: May 1, 2025
1 condition1 sponsor4 locations
NCT05430373
GT101 Injection for the Treatment of Metastatic or Recurrent Solid Tumors
PHASE1Recruiting
31 participants
Started: May 23, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor5 locations
NCT05430360
Autologous Tumor-infiltrating Lymphocyte Injection (GT201) for the Treatment of Metastatic/recurrent Advanced Solid Tumors
PHASE1Recruiting
30 participants
Started: Jan 4, 2022 · Completed: May 31, 2025
1 condition1 sponsor1 location
NCT06077903
GT101 Injection in the Treatment of Metastatic/Recurrent Advanced Solid Tumors
EARLY_PHASE1Recruiting
20 participants
Started: Jul 5, 2021 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT06088472
TIL Injection for the Treatment of Metastatic or Recurrent Solid Tumors
PHASE1Recruiting
12 participants
Started: Apr 21, 2021 · Completed: Dec 31, 2027
1 condition2 sponsors1 location